
Lentigen Corporation Announces Relocation to New Facility [pdf]
Invitrogen, Lentigen to Provide Lentivirus Products and Services for Gene Over-Expression [pdf]
Lentigen Corporation Receives Four Research Grants From The National Institutes of Health [pdf]
Lentigen Licenses Fundamental Lentiviral Vector Technology Patent from the University of Cambridge [pdf]
Lentigen Appoints Tim Ravenscroft as Chief Executive Officer [pdf]
Cell Genesys Announces Sale of Lentiviral Gene Delivery Technology for $12 Million [pdf]
Lentigen Corporation Partners with Thermo Fisher Scientific [pdf]
Lentigen Corporation Named Best Life Science Company in 7th Annual Maryland Incubator Company of the Year Awards [pdf]
Lentigen Corporation and Wave Biotech, LLC Announce Formation of Collaboration [pdf]
Lentigen Receives Grant from NIH to Develop Potential New Therapy for Treatment of Chronic Lymphocytic Leukemia [pdf]
Lentigen Announces Second Collaborative Research Agreement with the University of Pennsylvania [pdf]
Lentigen And Dharmacon Collaborate To Develop Custom Lentiviral Reagents For RNAi Research [pdf]
Lentigen Corporation and The University Of Pennsylvania Announce Collaborative Research Agreement [pdf]
Lentigen Corporation and United States Army Enter into a Cooperative Research and Development Agreement [pdf]
Lentigen Corporation and the University of Pennsylvania Enter Intellectual Property License Agreement [pdf]
Lentigen Corporation is Recipient of First Maryland Technology Champions Awards [pdf]
Lentigen Corporation and Evrogen JSC Enter License Agreement for Novel Fluorescent Protein Technology [pdf]
Lentigen Corporation and ZGene A/S Enter License Agreement for Selected ZGene Intellectual Property [pdf]
Lentigen Corporation Receives Funding from the State of Maryland [pdf]
Lentigen Corporation and Omnia Biologics Announce Strategic Alliance Related to Lentiviral Vector Manufacturing [pdf]
Lentigen Corporation Strengthens Management Team [pdf]
Lentigen Corporation Launches First Website Allowing On-line Custom Lentiviral Vector Design [pdf]
Omnia Biologics And Lentigen Sign Manufacturing Agreement [pdf]
UMBC Welcomes Another Biotechnology Company [pdf]

